Drug shortages remain one of the main challenges facing pharmacies in 2026. Whether it’s antibiotics, blood pressure medications, acetaminophen, or pediatric drugs, supply chain issues are on the rise and complicating daily life for both healthcare professionals and patients. 

Geopolitical tensions surrounding the Strait of Hormuzcould even exacerbate the situation in the coming months, particularly for certain generic drugs and antibiotics.  

Supply shortages are no longer limited to rare medications. Today, even some widely prescribed drugs are becoming difficult to obtain. For example, ablood pressure medication taken by nearly 50,000 people in France is currently facing anindefinitesupply shortage. Antibiotics also remain among the drugs most affected by stock shortages, particularly during the winter months when demand rises sharply. 

Given the scale of the problem,several European initiatives have recently been launched to ensure access to essential medicines. Drug shortages highlight the fragility of European supply chains and the lack of coordination among member states. 

The European Union is now working to build up strategic stockpiles, relocate certain production facilities, improve coordination among member states, and strengthen monitoring of critical medicines. 

In pharmacies, staff must manage these challenges on a daily basis by seeking alternative treatments, communicating with prescribers, reorganizing inventory, and supporting concerned patients. This situation places a significant additional workload on pharmacies, while reinforcing their essential role in ensuring continuity of care. 

To minimize the impact,authorities are emphasizing the importance of avoiding the unnecessary stockpiling of medications, advising patients not to discontinue their treatment without medical advice, directing patients to their local pharmacy in the event of unavailability, and offering recommended therapeutic alternatives whenever possible. 

Even though European and national authorities are stepping up measures to ensure a stable supply, drug shortages are expected to remain a major public health issue in the coming years.